New MR Breast Advanced application, Live Educational Webinar, and More Support Options
What’s New in Vitrea® Advanced Visualization 7.15
In addition to our current Vitrea Advanced Visualization applications, we continue to improve and enrich our clinical offerings across all modalities. Some of the enhancements in the latest version of Vitrea Advanced Visualization include:
- Olea Sphere® – MR Breast Advanced (Breastscape)*
- Olea Sphere® – MR Breast Biopsy (BreastLoc)
- Workflow Enhancements – Evidence Grouping and Export
Learn more by using our What’s New comparison tool.
*Olea Sphere® version 3.0 SP29 is integrated into Vitrea Advanced Visualization version 7.15. MR Breast Advanced and MR Breast Biopsy are powered by Olea Medical®
What’s New Software Version Comparison Tool
View software enhancements, technical features, and compare the latest software versions to see how you may benefit from an upgrade of your current version.
Live Clinical Webinar: Introduction to Vitrea Version 7
New to Vitrea version 7 or have questions about the interface? In this live webinar, a Vitrea instructor will go through an overview of the Vitrea version 7 interface. The instructor will hold a Q&A at the end of the webinar to answer any specific questions you may have.
Webinar Details:
Friday October 7, 2022
1:00-2:30 pm CST
How-To Video Highlight: Temporary Crosshair
Learn more about the temporary crosshair tool available in Vitrea Advanced Visualization
Looking for another specific tool? Check out these Vitrea How-To Demonstration videos for help on these and much more!
Online Support Case Filing
Did you know you can file your support case through MyVitrea? On portal.myvitrea.com, you have a simplified web experience and easier access to both support and clinical resources.
More from Canon Medical HIT
- Upcoming Events
- Canon Across America Tour | Coming to a city near you! Join us as we take the show on the road.
- RSNA, November 27 – December 1, Chicago, IL
Provide your feedback on how we can keep our newsletter relevant for you.